Definitive Contract 36C24418C0295

Award Date 10/1/18
Potential Completion Date 12/30/19
Potential Value $81K
Awardee
Sofie CO.
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Wilkes-Barre, PA, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $171,500.00 firm fixed-price purchase order has an ultimate completion date of April 4, 2019 and was awarded on October 1, 2016. This contract is not set aside and is part of Sofie's broader portfolio of federal contracts and indefinite delivery vehicles (IDVs) to supply specialized radiopharmaceuticals, including PET imaging agents and...
This federal contract award to Sofie CO., a subsidiary of Sofie Biosciences, Inc., provides PET/CT radiopharmaceuticals to the Department of Veterans Affairs (VA). The $2,343,583.08 fixed-price contract was set aside for small businesses and is scheduled for completion by September 30, 2023. Sofie CO. is a specialized manufacturer and supplier of molecular diagnostics and therapeutics, with extensive experience in positron emission tomography (PET) imaging. The company has been a key provider of...
This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
This definitive contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO. (Sofie), a for-profit organization, for the delivery of PET radiopharmaceuticals. The $116,720.00 firm fixed price contract has an April 1, 2019 completion date and did not utilize a set-aside. Sofie is an experienced provider of molecular diagnostics and therapeutics to federal agencies, including the VA, Defense Health Agency, and National Institutes of Health. The...
This federal contract award for $83,160.00 was made by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is a firm-fixed-price purchase order for the delivery of radiopharmaceuticals, including PET imaging agents and prostate cancer detection tools, to the San Francisco VA Medical Center. The award was made under a total small business set-aside. Sofie CO. has extensive...
This federal contract award, valued at $1,247,134.00, was issued by the Department of Veterans Affairs (VA) Network Contracting Office 21 to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the provision of Positron Emission Tomography (PET) radiopharmaceuticals to the VA San Francisco Health Care System. The contract has a base period of one year from October 1, 2023 to September 30, 2024, with four one-year option periods, resulting in a potential...
This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 awarded a $1.34 million firm fixed price delivery order contract to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The five year contract is for radiopharmaceutical PET imaging services to be performed in Sterling, Virginia. As the prime contractor, Sofie will provide radiopharmaceutical production and distribution to support positron emission tomography scans for...
This federal contract award was made by the Department of Veterans Affairs (VA) Veterans Health Administration to Sofie CO., a for-profit organization and expert in developing PET imaging and related molecular diagnostic and therapeutic products. The $257,650.00 firm fixed-price purchase order is for the delivery of PET test kits, with a completion date of November 27, 2018. The award was not subject to a set-aside designation. Sofie CO. is an experienced federal contractor, holding numerous...

This is a federal contract award to Sofie CO., doing business as Sofie, a for-profit organization specializing in the development and delivery of molecular diagnostics and therapeutics. The $80,750 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) to provide PET (Positron Emission Tomography) pharmaceuticals. The contract is part of the VA's VISN 4 (Veterans Integrated Service Network 4) program and has an ultimate completion date of December 30, 2019. Sofie has extensive experience supplying radiopharmaceuticals, including PET imaging agents and prostate cancer detection tools, to various federal agencies such as the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH). This contract award is not associated with a set-aside designation.

Generated 4/1/25, 6:20 PM